Earlier, the Center for Diagnostics and Telemedicine of the Moscow Department of Health and RTU MIREA signed a landmark agreement to jointly develop and deliver specialized training programs in artificial intelligence applied to healthcare. This collaboration resulted in the creation of a unique, and at the time, the only joint educational program integrating scientific knowledge and practical expertise gained from the Moscow Experiment on computer vision implementation. The program combines the Center’s hands-on experience with the university’s foundational competencies in mathematics and computer science. Additionally, practitioners from Third Opinion Platform, a leading Russian AI healthcare developer, contributed to curriculum development and student training.
On June 10, 2025, the inaugural graduation ceremony was held for the first master's students of the Intelligent Data Analysis program within the Computer Science and Computer Engineering faculty.
Graduates have already showcased impactful healthcare innovations, including an algorithm for early detection of liver tumors with 85% accuracy and complex medical decision support systems. These projects received recognition at the All-Russian Engineering Competition, where one student emerged as the winner and six others were laureates. These advancements are poised to significantly reduce the interval between oncological disease detection and surgical intervention.
Anton Vladzimirsky, Deputy Director of R&D at the Center for Diagnostics and Telemedicine of the Moscow Department of Health, emphasized:
"The integration of artificial intelligence into medical practice is becoming a reality through the training of highly qualified specialists. Our graduates possess a unique combination of skills that enable them to develop cutting-edge solutions for digital medicine and drive the advancement of intelligent healthcare technologies."
Stanislav Kudzh, Rector of RTU MIREA, added:
"The achievements of the first graduates of the AI Data Analysis program demonstrate that deep interdisciplinary training is essential for the successful integration of AI into medical practice. These specialists have not only mastered advanced technologies but have also contributed practically to digital medicine’s development. They are set to become leaders in creating innovative solutions that will enhance healthcare quality and accelerate the adoption of intelligent technologies across Russia. This represents a significant milestone in the evolution of healthcare."
About RTU MIREA
RTU MIREA (Russian Technological University) is a multidisciplinary state university educating over 30,000 students across various modalities. The university’s Institute of Artificial Intelligence offers 17 specialized programs and annually graduates hundreds of programmers and AI experts. With more than 250 educational programs spanning IT, radio electronics, chemistry, biotechnology, and robotics, RTU MIREA actively integrates industry practices from high-tech companies into its curriculum.
About the Center for Diagnostics and Telemedicine of the Moscow Health Department
The Center for Diagnostics and Telemedicine is a leading scientific and practical institution within the Moscow Health Department. It oversees the development of diagnostic services, drives digital transformation in healthcare, implements AI technologies in clinical practice, conducts research, and provides medical workforce training. Since 2013, the Center has produced over 800 scientific publications and registered more than 200 intellectual property results. Since 2020, it has been conducting an experiment deploying computer vision technologies, analyzing over 14 million medical images across 40+ clinical areas with high accuracy. By presidential directive, the Center operates MosMedAI, a digital platform offering AI-powered medical image processing and automated radiology analysis, currently adopted by 71 Russian regions.
About Third Opinion Platform
Third Opinion Platform is a Russian developer of AI-powered diagnostic support tools for radiology and laboratory medicine, including a proprietary smart video analytics system. Its algorithms detect over 100 pathological indicators, such as breast cancer, stroke, lung cancer, and aortic aneurysm. The platform is implemented across 58 Russian regions and in private clinics, including the European Medical Center (EMC). To date, its AI solutions have processed over 10 million clinical studies. The company’s flagship products are registered as Class III medical devices by Roszdravnadzor. Since 2020, Third Opinion Platform has partnered strategically with MEDSI Group, one of Russia’s largest private healthcare networks.